Urine drug testing in the treatment of chronic noncancer pain in a Kentucky private neuroscience practice: The potential effect of medicare benefit changes in Kentucky

Pain Physician

Volumn 13, Issue 2, 2010, Pages 187-194

  Gilbert, John W ^a   Wheeler, G R ^a   Mick, G E ^a   Storey, B B ^a   Herder, S L ^a   Richardson, G B ^a   Watts, E ^a   Gyarteng Dakwa, K ^a   Marino, B S ^a   Kenney III, C M ^a   Siddiqi, M ^a   Broughton, P G ^a  

^a Spine and Brain Neurosurgical Center   (United States)

Author keywords

Chronic noncancer pain; Drug abuse; Medicaid; Medicare; Opioids; Urine drug testing

Indexed keywords

OPIATE;

ARTICLE; CHRONIC PAIN; COMPUTER PROGRAM; DRUG SCREENING; HUMAN; MASS FRAGMENTOGRAPHY; MEDICAID; MEDICAL PRACTICE; MEDICAL SERVICE; MEDICARE; OUTCOME ASSESSMENT; PRIVATE PRACTICE; UNITED STATES; URINALYSIS; URINE DRUG TEST;

ANALGESICS, OPIOID; HUMANS; KENTUCKY; MEDICARE; OPIOID-RELATED DISORDERS; PAIN CLINICS; PAIN, INTRACTABLE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PREDICTIVE VALUE OF TESTS; REIMBURSEMENT MECHANISMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; UNITED STATES; URINALYSIS;

EID: 77950684928     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ballantyne J. Opioid analgesia: Perspectives on right use and utility. Pain Physician 2007; 10:479-481.
2. Manchikanti L, Singh A. Therapeutic opioids: A ten-year perspective on the complexities and complications of escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11:S63-S88.
3. Ballantyne J, Mao J. Opioid therapy for chronic pain. New Engl J Med 2003; 349:1943-1953.
4. Trescot AM, Helm S, Hansen H, Benyamin R, Glaser S, Adlaka R, Patel S, Manchikanti L. Opioids in the management of chronic non-cancer pain: An update of the American Society of Interventional Pain Physicians' (ASIPP) guidelines. Pain Physician 2008; 11:S5-S62.
5. Smith H. Peripherally-Acting Opioids. Pain Physician 2008; 11:S121-S132.
6. Trescot AM, Datta S, Lee M, Hansen H. Opioid Pharmacology. Pain Physician 2008; 11:S133-S153.
7. Trescot AM, Glaser SE, Hansen H, Benyamin RM, Patel S, Manchikanti L. Effectiveness of Opioids in the treatment of chronic non-cancer pain. Pain Physician 2008; 11:S181-S200.
8. Manchikanti L, Atluri S, Trescot AM, Giordano J. Monitoring opioid adherence in chronic pain patients: Tools, techniques, and utility. Pain Physician 2008; 11:S155-S180.
9. Manchikanti L, Manchukonda R, Damron K, Brandon D, McManus C, Cash K. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006; 9:57-60.
10. Manchikanti L, Fellows B, Damron KS, Pampati V, McManus CD. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends. J Ky Med Assoc 2005 Feb; 103(2):55-62.
11. Manchikanti KN, Manchikanti L, Damron KS, Pampati V, Fellows B. Increasing deaths from opioid analgesics in the United States: An evaluation in an interventional pain management practice. J Opioid Manage 2008; 4:271-283.
12. Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manage 2007; 3:89-100.
13. Manchikanti L, Benyamin RM. Longterm opioid therapy. Pain Pract 2009; 9:164.
14. Manchikanti L, Manchikanti KN, Pampati V, Cash KA. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Pain Physician 2009; 12:259-267.
15. Manchikanti L, Pampati V, Damron KS, McManus CD. Evaluation of variables in illicit drug use: Does a controlled substance abuse screening tool identify illicit drug use? Pain Physician 2004; 7:71-75.
16. Gilbert JW, Wheeler GR, Lingreen RA, Martonffy D, Hatchett J, Gaines R, Stidham S, Sutton T, Westerfield G, McConnell M, Noble S, Carter K. The ten Cs of chronic noncancer pain: Universal precautions for the chronic noncancer pain patient. Am J Pain Manage 2005; 15:22-32.
17. Narconon International. Signs and symptoms of drug use. www.narconon.org/parent_center/signs_symptoms. Accessed: May 29, 2009
18. Centers for Medicare and Medicaid Services. Qualitative drug screening L28145. www.ngsmedicare.com/NGSMedicare/lcd/DL28145_f_lcd.htm.
19. U.S. Department of Health and Human Services. Summary of findings from the 2000 national household survey on drug abuse. In: Substance Abuse and Mental Health Services Administration, editor.; 2000.
20. Buck J, Miller K. Mental health and substance abuse services in Medicaid, 1995. DHHS Pub. No. (SMA) 02-3713. Rockville, MD: Center for Mental Health Services, Substance Abuse and Mental Health Services Administration, 2002.
21. Goldfarb B. Primary care physicians often miss signs of drug abuse in pain patients. Pain Med News 2005; 3:6.
22. Kentucky Board of Medical Licensure: Model guidelines for the use of controlled substances in pain treatment. J Ky Med Assoc 2001; 99:291-294.
23. Campbell A. American Academy of Pain Management Pain Program Accreditation: Description and value. www.sbncmd.com/Pain%20Management%20Program%20Accreditation.pdf. Accessed June 25, 2009.
24. Kozma A. Urine drug screening in everyday practice. Practical Pain Management 2007 (April): 18-20.
25. Evans M, Ma'Ayteh B, Constantine J. Guest editorial. Practical Pain Management 2005 (Jul/Aug).